GSK (NYSE: GSK) has a new mission and that mission is to go after major medical conditions that have no treatment. The...
Vaccines have less efficacy with COVID-19 variants Key 3CL protease inhibitors shows promise for any COVID-19 variants, and potentially all coronav...
Enrollment Key Metric in Therapeutic Race Philippines EUA Relevant to CytoDyn, not Humanigen Highly Credentialed Humanigen Team Possibility of NAS...
CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...
Developing a vaccine to treat COVID-19 is hands down the best way to play the long term coronavirus stocks. Ultimately a vaccine...
It’s only been a week or so since we last looked at Pernix Therapeutics Holdings Inc (NASDAQ:PTX), with our focus at that...
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) is in a bit of a tough position right now and has spent the last six months...
Pernix Therapeutics Holdings Inc (NASDAQ:PTX) is in a bit of a tough position right now and has spent the last six months...
GlaxoSmithKline plc (NYSE:GSK) recently released third quarter earnings of GBP0.28 a share, GBP0.04 improved than the Capital IQ Consensus anticipates of GBP0.24;...
EMC Corporation (NYSE:EMC), Cisco, and VCE declared on Wednesday that the next phase of evolution for VCE. Anticipated to be finalized this...